Occult hepatitis B infection  by Pollicino, Teresa & Raimondo, Giovanni
1Division of Clinical and Molecular H
*Corresponding a
Received 12 January 2014; rece
Keywords: Occult HBV infection
Occult hepatitis B virus (HBV) infe
[1]. OBI defines the persistence of
and, usually, also for serum HBV D
heterogeneity (i.e., infection with re
diagnostic kits), in most cases OB
transcriptional) by the host’ s defen
low-levels of replication and transc
reactivation and development of a
Key facts
Fig. 1 Schematic comparison of overt and o
(presence of functionally ef ficient central/effec
genome as well as acetylation/methylation of c
(HBV RNA splicing, HBV replication inhibition 
nucleosomal packaging and transcriptional act
displayed. DC, Dendritic Cell; CD4, CD4+ T ce
proteins; SVPs, subviral particles; TF, cellular t
polypeptide; hnRNP K, heterogeneous nuclear
“Overt” HB 
Hepatology Snapshot
Open access under CC BY-NC-NDOccult Hepatitis B InfectionJournal of Hepatology 2014 vol  61 | 688–689
Teresa Pollicino1,2,*, Giovanni Raimondo1,3,*
epatology, 2 Department of Pediatric, Gynecologic, Microbiology and Biomedical Science, 3 Department of Clinical 
and Experimental Medicine. University Hospital of Messina, Messina, Italy.
Tel.: +39.090.2217070; fax: +39.090.2213594.
uthors. E-mail addresses: tpollicino@unime.it (T. Pollicino), raimondo@unime.it (G. Raimondo).
ived in revised form 21 April 2014; accepted 24 April 2014 
, immunological control of HBV, epigenetic control of HBV, clinical implication of occult HBV infection
ction (OBI) is recognized as one of the possible phases in the natural history of chronic HB V infection 
 HBV genomes in the hepatocytes of individuals testing negative for HBV surface antigen (HBs Ag) 
NA [2]. Apart from some cases in which the lack of HBsAg detection is attributable to the HBV  genetic 
plication-defective variants or with S-escape mutants producing a modified HBsAg undetect able by 
I is related to replication-competent viruses that are strongly suppressed in their activities (replicative and 
se mechanisms. Very importantly, this suppression (a) does not have an absolute ef fect and residual, 
ription may persist over time, and (b) may be reversible in particular circumstances leadin g to viral 
 typical HBsAg-positive (namely, “overt”) infection [3].
Therapy
ccult HBV infection.  Mechanisms potentially involved in HBV inhibition and OBI induction are summarized. In particular , immunological 
tor memory T cells), genetic (HBV genomic variability , APOBEC hyperediting), epigenetic (methylation of CpG-rich regions within the HBV 
ccDNA-bound histones and recruitment of chromatin modifying enzymes onto the vira l minichromosome) and co-/posttranscriptional 
by cellular miRNAs and by editing-independent functions of the cellular APOBEC3 proteins) mechanisms are represented. Dif ferences in 
ivity of HBV minichromosomes as well as in amounts of total viral DNA, transcripts , proteins and virion formation and secretion are also 
ll; CD8, CD8+ T cell; RC DNA, Relaxed Circular DNA; cccDNA, covalently closed circ ular DNA; pgRNA, pregenomic RNA; HBs, envelope 
ranscription factors; HATs, histone acetyl transferases; HMT, histone methyltransferases; APOBEC3, apo B mRNA editing enzyme catalytic 
 ribonucleoprotein K; miRNAs, microRNAs; CpG meth, methylated CpG islands.
V infection “Occult” HBV infection  
 license.
Key Points Key Points (continued)
• The molecular basis of the occult infection is closely related to 
the peculiar life cycle of the HBV, and in particular to the long-
lasting persistence of free viral genomes – such as HBV cccDNA 
chromatinized episomes – in the nucleus of the infected cells. 
The stability and long-term persistence of cccDNA molecules 
together with the long half-life of hepatocytes imply that HBV 
infection, once it has occurred, may possibly continue for life 
even in conditions of strong inhibition of viral functions [4]
• HBV DNA can integrate in the host’s genome. Integration 
has no role in the replicative cycle of HBV and it involves only 
segments of the viral DNA. Integrated HBV may persist forever 
in the liver cells of infected individuals, independently of the 
HBsAg positive/negative status. The presence of integrated viral 
DNA in HBsAg-negative subjects does not per se have to be 
identified as an occult infection, since OBI is essentially related 
to the intrahepatic persistence of entire, episomal, replication-
competent HBV genomes
• A not negligible portion of OBI cases are negative for all HBV 
serum markers (OBI seronegative): they might have either 
progressively lost the anti-HBV antibodies or might be HBV 
antibody negative since the beginning, as a consequence of 
a very limited number of virions in the infecting inoculums, in 
analogy to what was observed in the woodchuck model of 
hepadnavirus infection [5] 
• Growing evidence indicates that genetic (i.e., HBV genomic 
variability, APOBEC deamination-dependent activity), 
epigenetic (i.e., methylation of CpG-rich regions within the 
HBV genome as well as acetylation/methylation of cccDNA-
bound histones and recruitment of chromatin modifying 
enzymes onto the viral minichromosome) and co-/post-
transcriptional mechanisms (i.e., viral RNA splicing, miRNAs 
effects, APOBEC deamination-independent activity) may 
be involved in the control of HBV replication and gene 
expression, and thus in the OBI occurrence [3,6] (Fig. 1). 
Most of these mechanisms might be triggered by the host’s 
immune response. Indeed, OBI subjects show long-lasting, 
potent, and multispecific HBV T cell responses (although 
with a profile that is different between OBI-seropositive 
and OBI-seronegative individuals) [7,8]. Based upon the 
present knowledge of HBV immunopathogenesis, it may be 
proposed that in overt chronic HBV infection anti-viral T cell 
dysfunction is maintained by different mechanisms, including 
the persistent exposure to high antigen loads, that precludes 
the generation of functionally efficient memory T cells. In 
occult infection, traces of virus are tightly controlled by the 
presence of functionally efficient central/effector memory 
T cells that are able to rapidly differentiate into effector 
cells. Moreover, also the innate immune response might be 
involved in suppression of HBV replication through non-
cytolytic, immune-mediated mechanisms [9]
• In vitro studies showed that the replication, transcription, 
and protein synthesis capabilities of HBV isolates from liver 
of OBI individuals can be fully restored once the viruses are 
taken out of the host’s microenvironment [10]. In analogy, 
the profound changes of the host’s immune surveillance 
mechanisms observed mainly in patients with hematological 
malignancies undergoing immune- and/or chemo-
therapies have been shown to lead to OBI reactivation with 
consequent development of acute hepatitis showing the 
typical serological profile of acute hepatitis B (HBsAg (re)-
appearance and even HBeAg positivity)  [3]. Finally, a similar 
scenario may occur in HBV-naïve patients undergoing liver 
transplantation: if the donor is OBI positive, the recipient 
may develop typical hepatitis B (when a proper anti-HBV 
prophylaxis is not performed) [3]
• Longitudinal evaluation of serum HBV DNA in OBI patients 
shows phases of absent viremia alternating with phases of 
very low but detectable viral load. These episodes of transient, 
partial viral reactivation may be associated with a slight increase 
of transaminase levels [11]. Various studies indicated that OBI 
is associated with the most severe forms of chronic hepatitis 
(particularly in HCV-infected patients), thus suggesting that it 
might favor or accelerate the progression toward cirrhosis of 
patients with various causes of liver disease [3,12,13] 
   
• Many studies indicate that OBI is an important risk factor for 
hepatocellular carcinoma development [3,13,14]. In fact, OBI 
may maintain most of the pro-oncogenic properties of the overt 
HBV infection, including the capacity to integrate into the host’s 
genome, to produce proteins with transforming properties (even if 
at low levels) and a mild but persisting necroinflammation
• Reliable OBI diagnosis can at present be performed only in highly 
specialized laboratories. The development in the near future of 
valid and commercially available assays (i.e., real time PCR on 
DNA extracts from liver tissue fine-needle aspiration) allowing the 
detection of OBI in all cases, in which its presence might be of 
clinical relevance, appears of great importance
Journal of Hepatology 
  © 2014 European Association for the Study of the Liver. Published by 
Elsevier B.V. Open access under CC BY-NC-ND license.Conflict of interest
The authors declared that they do not have anything to disclose 
regarding funding or conflict of interest with respect to this manuscript.
Acknowledgements
The authors are grateful to Prof. Carlo Ferrari for his helpful comments 
and suggestions.
 References
  [1]   EASL Clinical Practice Guidelines: management of chronic hepatitis B virus in fec-
tion. J Hepatol 2012;57:167–185.
   [2]   Raimondo G, Allain JP, Brunetto MR, Buendia MA, Chen DS, Colombo M et al. 
Statements from the Taormina expert meeting on occult hepatitis B virus infection. 
J Hepatol 2008;49:652–657.
    [3]   Raimondo G, Caccamo G, Filomia R, Pollicino T Occult HBV infection. Semin Im-
munopathol 2013;35:39–52
   [4]   Zoulim F. New insight on hepatitis B virus persistence from the study of intrahepatic 
viral cccDNA. J Hepatol 2005;42:302–8.
   [5]   Michalak TI, Mulrooney PM, Coffin CS. Low doses of hepadnavirus induce infection 
of the lymphatic system that does not engage the liver. J Virol 2004;78:1730–8.
   [6]   Levrero, M., Pollicino, T., Petersen, J., Belloni, L., Raimondo, G., & Dandri, M. 
(2009). Control of cccDNA  function in hepatitis B virus infection. J. Hepatol. 51, 
581–592.
   [7]   Zerbini, A., Pilli, M., Boni, C., Fisicaro, P., Penna, A., Di, V. P., Giuberti, T., et al. The 
characteristics of the cell-mediated immune response identify dif ferent profiles of 
occult hepatitis B virus infection. Gastroenterology, 2008;134:1470–1481.
   [8]   Bes, M., Vargas, V., Piron, M., Casamitjana, N., Esteban, J. I., Vilanova, N., et al. T 
cell responses and viral variability in blood donation candidates with occult hepatitis 
B infection. J Hepatol 2012;56:765–774.
   [9]   Guidotti LG, Chisari FV . Noncytolytic control of viral infections by the innate and 
adaptive immune response. Annu Rev Immunol 2001;19:65–91.
 [10]   Pollicino T, Raffa G, Costantino L, Lisa A, Campello C, Squadrito G, et al. Molecular 
and functional analysis of occult hepatitis B virus isolates from patients with hepa-
tocellular carcinoma. Hepatology 2007;45:277–285.
 [11]   Chemin, I., Guillaud, O., Queyron, P . C., & Trepo, C. (2009). Close monitoring of 
serum HBV DNA levels and liver enzymes levels is most useful in the management 
of patients with occult HBV infection. J. Hepatol. 51, 824–825.
 [12]   Covolo L, Pollicino T, Raimondo G, Donato F . Occult e patiti B virus and risk for 
chronic liver disease: A meta-analysis. Dig Liv Dis 2013;45:238–24.
 [13]   Squadrito G, Cacciola I, Alibrandi A, Pollicino T, Raimondo G. Impact of occult epatiti 
B virus infection on the outcome of chronic hepatitis C. J Hepatol 2013;59:696–700.
 [14]   Shi Y, Wu YH, Wu W, Zhang WJ, Yang J, Chen Z. Association between occult 
hepatitis B virus infection and the risk of hepatocellular carcinoma: a meta-analysis.
Liver Int 2012;32:231–240.2014 vol  61 | 688–689 689
